newsfilter
← Latest News
GlobeNewswire·

Aravive Reports Second Quarter 2022 Financial Results and Provides Corporate Updates

Hosted Key Opinion Leader (KOL) Symposium; KOLs Presented Positive Updated Batiraxcept Phase 1b Clear Cell Renal Cell Carcinoma (ccRCC) and Phase 1b Pancreatic Adenocarcinoma Data. Presented Updated Clinical Data at ASCO Showing Continued Best-In-Class